| abstract |
The invention relates to solid retigabine in non-crystalline form together with a surface stabilizator in form of a stable intermediate. In the intermediate according to the invention, retigabine is preferably present in amorphous form or in the form of a solid solution. The invention further relates to methods for producing retigabine in solid, non-crystalline form and to pharmaceutical formulations, containing solid, non-crystalline retigabine. |